Company intelligence / Profile preview
Tesio Pharmaceuticals
- Ownership
- Private
- Employees
- ~3
- Development stage
- Other
Overview
Tesio Pharmaceuticals is a private U.S. biotech developing next-generation anti-inflammatory therapies that combine kinase inhibition with targeted local drug delivery and extended-duration formulations. The company’s approach is designed to suppress inflammatory gene activation while limiting systemic exposure and reducing steroid-related side effects. Tesio’s disclosed lead disease areas are lung fibrosis and osteoarthritis, with patent activity centered on local and inhaled formulations of CDK9 inhibitors. The company appears to be an early-stage, preclinical therapeutics developer with a strong drug-delivery focus.
- Therapeutic areas
- RheumatologyImmunologyPulmonology
- Modalities
- Small molecule
- Industry
- Biotech
Drug pipeline
1 assetPartnerships
Beyond the preview
Go deeper on Tesio Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tesio Pharmaceuticals.